COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥11 | CN¥10 | CN¥10 | CN¥10 |
| - Cash | CN¥3 | CN¥2 | CN¥2 | CN¥2 |
| + Debt | CN¥4 | CN¥4 | CN¥5 | CN¥4 |
| Enterprise Value | CN¥13 | CN¥12 | CN¥13 | CN¥13 |
| Revenue | CN¥4 | CN¥4 | CN¥4 | CN¥5 |
| % Growth | 0.5% | 0.9% | -11% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 7.1% | 6.8% | 8.1% | 0.4% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| % Margin | 0.3% | 3.7% | 5.2% | -3.4% |
| Net Income | -CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | -0.6% | 1.5% | 0.9% | 0.3% |
| EPS Diluted | -0.015 | 0.036 | 0.022 | 0.008 |
| % Growth | -142.1% | 64.7% | 159.5% | – |
| Operating Cash Flow | CN¥0 | CN¥1 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥1 | -CN¥0 | -CN¥0 |